Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers
Status:
Completed
Trial end date:
2017-03-29
Target enrollment:
Participant gender:
Summary
Primary Objectives:
To evaluate the safety and tolerability of escalating single and multiple doses of X0002
administered as a topical application.
Secondary Objectives:
To characterize the single and and multiple pharmacokinetics of escalating doses of X0002 and
its active metabolite ibuprofen as a topical application.